129 results
Page 4 of 7
8-K
EX-99.1
yo6l izgzneq
29 Jul 21
Stock Purchase Agreement
4:15pm
8-K
ri9o2a
23 Jun 21
Submission of Matters to a Vote of Security Holders
4:55pm
DEFA14A
2cgu7z6x7qo1f4hcyb1
30 Apr 21
Additional proxy soliciting materials
12:00am
8-K
EX-1.1
asrrnox7e
8 Apr 21
Crinetics Pharmaceuticals Announces Pricing of Public Offering of Common Stock
4:09pm
424B5
g0atvd4
8 Apr 21
Prospectus supplement for primary offering
4:07pm
S-8
gg0 pp1n84gopri222y
31 Mar 21
Registration of securities for employees
12:00am
S-8
EX-23.2
ch3zw1p4b1jx94icdw
31 Mar 21
Registration of securities for employees
12:00am
8-K
EX-99.1
i4hv2q c8
26 Oct 20
Regulation FD Disclosure
6:55am
8-K
EX-99.1
c18baci9e
3 Sep 20
Crinetics Pharmaceuticals Appoints Rare Disease Executive, Camille L. Bedrosian, M.D., to Board of Directors
7:35am
8-K
funcdcrd02zmggsx8m
3 Sep 20
Crinetics Pharmaceuticals Appoints Rare Disease Executive, Camille L. Bedrosian, M.D., to Board of Directors
7:35am
8-K
gmzz 2y975ebk
22 Jun 20
Submission of Matters to a Vote of Security Holders
4:05pm
DEFA14A
memfz 4q4rvey
28 Apr 20
Additional proxy soliciting materials
4:10pm
424B5
gsm56kt ll
15 Apr 20
Prospectus supplement for primary offering
4:16pm
8-K
EX-1.1
7ts9zwa
15 Apr 20
Crinetics Pharmaceuticals Announces Proposed Public Offering of Common Stock
4:06pm
424B5
zkol6tm8txh 8mr2c
14 Apr 20
Prospectus supplement for primary offering
4:49pm